GlassScriptPhysician profile
Katherine Bishop
NPI 1912392796
$1,146.65
in general payments reported to CMS, 2019-2025
18 companies · $427 in 2025
The $427 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.37 · 2021: $24.82 · 2022: $133 · 2023: $293 · 2024: $227 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.15 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $205.36 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $136.49 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.12 | 2023-2025 | |
| Hologic Sales and Service, LLC | $95.24 | 2022-2025 | Acessa Provu System, Aptima |
| Sumitomo Pharma America, INC. | $78.53 | 2023 | Myfembree |
| Exeltis, USA INC. | $76.96 | 2021-2025 | Slynd |
| Davol INC. | $76.69 | 2021-2022 | |
| Boston Scientific Corporation | $53.74 | 2019-2022 | |
| Coopersurgical, INC. | $48.98 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Optumhealth Care Solutions, LLC | $48.50 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Organon LLC | $44.61 | 2024-2025 | Nexplanon |
| Abbvie INC. | $43.26 | 2023-2024 | Orilissa |
| Amgen INC. | $28.58 | 2025 | Prolia, Evenity |
| Biogen, INC. | $24.43 | 2025 | Zurzuvae |
| Millicent US INC | $17.52 | 2025 | Intrarosa, Femring |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.99 | 2024 | |
| Agile Therapeutics, INC. | $13.62 | 2023 | Twirla |
| Medtronic, INC. | $13.03 | 2023 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.